FDA Inspection 1309552 — Blood Center (The) Mandeville Donor Center
The FDA completed an inspection of Blood Center (The) Mandeville Donor Center on March 24, 2026 in Mandeville, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 24, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Mandeville, LA (United States)